Search results
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 7 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
This Rx-Only Wound Cream Is Like Your Daily Moisturizer on Steroids
Robb Report via Yahoo News· 5 days ago“Hyalo4 is commonly prescribed for post-procedure care such as laser treatments and chemical peels,”...
Here Comes the Sun: We Are Your Summer Skincare Experts
Lancaster Online· 4 days agoSummer is finally here and, for most of us, that means more time in the sun - whether it’s relaxing...
Phantom Cell Lines Undermine Cancer Research Credibility
Medscape· 6 days agoThis superficiality was illustrated by an image, created by artificial intelligence, of a mouse with...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo Finance· 2 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
Spartan Planning & Wealth Management Sells 194 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoSpartan Planning & Wealth Management cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.3% in the fourth quarter, according to the company in its most recent disclosure ...
Polycystic Ovarian Syndrome: New Science Offers Old Remedy
Medscape· 6 days agoAn ancient Chinese remedy for malaria could offer new hope to the 10% of reproductive-age women...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 4 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 5 days agoSkyrizi’s approval for the UC indication was based on data from two phase III studies, a 12-week induction study, INSPIRE1 and a 52-week maintenance study, COMMAND2. Skyrizi is already approved ...
Cryogenic chambers and infrared capsules. This ‘fitness hotel’ is taking wellness tech to the next...
CNN.com· 3 days agoEditor’s Note: This CNN series is, or was, sponsored by the country it highlights. There are...